How common is non‐alcoholic fatty liver disease in the Asia–Pacific region and are there local differences?

Risk factors for development of non‐alcoholic steatohepatitis include obesity, especially central adiposity, glucose intolerance or type 2 diabetes mellitus (T2DM), and dyslipidemia. Non‐alcoholic fatty liver disease (NAFLD) is now considered a manifestation of metabolic syndrome. During the last two decades, NAFLD has become the most common chronic liver disease in North America and Europe, but until recently was thought to be uncommon (perhaps due to the lack of study) in Asia. Fatty liver can be identified on imaging modalities (ultrasonography, computed tomography scans, and magnetic resonance imaging) with high sensitivity, but steatohepatitis and fibrosis cannot be distinguished. Thus, an inherent drawback in studying the epidemiology of NAFLD is the lack of definitive laboratory tests, no uniform definition—with different studies using cut‐off values of alcohol consumption from <20 g/week to 210 g/week, and case selections where biopsy was used for definition. In studies outside the region, the prevalence of NAFLD varies from 16% to 42% by imaging, and 15–39% of liver biopsies. The major risk factors for NAFLD, central obesity, T2DM, dyslipidemia, and metabolic syndrome, are now widely prevalent and are increasing geometrically in the Asia–Pacific region. It is therefore not surprising that NAFLD is common in this region. Estimates of current prevalence range from 5% to 30%, depending on the population studied. Central obesity, diabetes, and metabolic syndrome are the major risk factors. To date, however, data on the natural history and impact of NAFLD causing serious significant chronic liver disease are lacking and there is a need for prospective, cooperative studies.

[1]  K. Mumtaz,et al.  Enteric fever: do elevated liver enzymes influence outcome? , 2009 .

[2]  A. Dassanayaka,et al.  Clinical, biochemical and histological characteristics of a Sri Lankan population of non-alcoholic steatohepatitis (NASH) patients. , 2009, The Ceylon medical journal.

[3]  Z. Bıyıklı,et al.  Non-alcoholic steatohepatitis with normal aminotransferase values. , 2009, World Journal of Gastroenterology.

[4]  A. McCullough The Epidemiology and Risk Factors of NASH , 2007 .

[5]  T. Saibara,et al.  Non‐alcoholic fatty liver disease in the Asia–Pacific region: Definitions and overview of proposed guidelines , 2007, Journal of gastroenterology and hepatology.

[6]  G. Lau,et al.  Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia–Pacific region: Executive summary , 2007, Journal of gastroenterology and hepatology.

[7]  T. Saibara,et al.  What are the risk factors and settings for non‐alcoholic fatty liver disease in Asia–Pacific? , 2007, Journal of gastroenterology and hepatology.

[8]  Jian-Gao Fan,et al.  The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers , 2007, Journal of gastroenterology and hepatology.

[9]  R. Dhiman,et al.  The Clinicopathological Profile of Indian Patients with Nonalcoholic Fatty Liver Disease (NAFLD) is Different from That in the West , 2007, Digestive Diseases and Sciences.

[10]  P. Cheah,et al.  Non‐alcoholic fatty liver disease in Malaysia: A demographic, anthropometric, metabolic and histological study , 2007, Journal of Digestive Diseases.

[11]  A. McCullough Thiazolidinediones for nonalcoholic steatohepatitis--promising but not ready for prime time. , 2006, The New England journal of medicine.

[12]  Ho-Young Son,et al.  Epidemic obesity and type 2 diabetes in Asia , 2006, The Lancet.

[13]  Chien-Hua Chen,et al.  Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in an Adult Population of Taiwan: Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese Adults , 2006, Journal of clinical gastroenterology.

[14]  V. Wong,et al.  Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  V. Mohan,et al.  Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India—the Chennai Urban Rural Epidemiology Study (CURES-17) , 2006, Diabetologia.

[16]  Y. Cho,et al.  Prevalence and risk factors of non‐alcoholic fatty liver disease among Korean adults , 2006, Journal of gastroenterology and hepatology.

[17]  Shi-yao Chen,et al.  Fatty liver and the metabolic syndrome among Shanghai adults , 2005, Journal of gastroenterology and hepatology.

[18]  Y. Iwamoto,et al.  Prevalence of non‐alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[19]  Shi-yao Chen,et al.  Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. , 2005, Journal of hepatology.

[20]  Chih‐Lin Lin,et al.  Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan. , 2005, World journal of gastroenterology.

[21]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[22]  M. Manos,et al.  Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease , 2005, Hepatology.

[23]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[24]  K. Madan,et al.  Role of polymerase chain reaction and liver biopsy in the evaluation of patients with asymptomatic transaminitis: Implications in diagnostic approach , 2004, Journal of gastroenterology and hepatology.

[25]  J. George,et al.  Fatty liver disease: NASH and related disorders , 2004 .

[26]  D. Amarapurkar,et al.  Non‐alcoholic steatohepatitis in type 2 diabetes mellitus , 2004, Journal of gastroenterology and hepatology.

[27]  D. Amarapurkar,et al.  Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferase values. , 2004, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[28]  H. Kim,et al.  Insulin resistance and C‐reactive protein as independent risk factors for non‐alcoholic fatty liver disease in non‐obese Asian men , 2004, Journal of gastroenterology and hepatology.

[29]  E. Tai,et al.  Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? , 2004, Diabetes care.

[30]  J. George,et al.  Non‐alcoholic steatohepatitis in the Asia–Pacific region: Future shock? , 2004, Journal of gastroenterology and hepatology.

[31]  Kai-Hong Huang,et al.  Clinical features and risk factors of patients with fatty liver in Guangzhou area. , 2004, World journal of gastroenterology.

[32]  Jian-Gao Fan,et al.  Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey. , 2003, World journal of gastroenterology.

[33]  F. Brancati,et al.  The prevalence and etiology of elevated aminotransferase levels in the United States , 2003, American Journal of Gastroenterology.

[34]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.

[35]  G. Farrell Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region? , 2003, Journal of gastroenterology and hepatology.

[36]  C. Yajnik,et al.  Neonatal anthropometry: the thin–fat Indian baby. The Pune Maternal Nutrition Study , 2003, International Journal of Obesity.

[37]  Hajime Isomoto,et al.  Fatty liver in non‐alcoholic non‐overweight Japanese adults: Incidence and clinical characteristics , 2002, Journal of gastroenterology and hepatology.

[38]  P. Angulo,et al.  Nonalcoholic fatty liver disease. , 2002, Revista de gastroenterologia de Mexico.

[39]  R. Karim,et al.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.

[40]  D. Simonson,et al.  Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. , 2001, The Journal of clinical endocrinology and metabolism.

[41]  K. Yamaoka,et al.  Test validity of periodic liver function tests in a population of Japanese male bank employees. , 2001, Journal of clinical epidemiology.

[42]  S. Sarin,et al.  Clinical, biochemical and histological profile of nonalcoholic steatohepatitis. , 2001, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[43]  M. Ishizaki,et al.  Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people. , 1995, Journal of human hypertension.

[44]  K. Suzuki,et al.  Obesity and liver disease: evaluation of fatty infiltration of the liver using ultrasonic attenuation. , 1991, Journal of nutritional science and vitaminology.

[45]  K. Okuda,et al.  Frequency of abnormalities detected by abdominal ultrasound among Japanese adults , 1991, Journal of Gastroenterology and Hepatology.

[46]  H. Nomura,et al.  Prevalence of fatty liver in a general population of Okinawa, Japan. , 1988, Japanese journal of medicine.

[47]  G. Farrell,et al.  LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis , 2006 .

[48]  Tetsuji Sato,et al.  The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. , 2006, Annals of internal medicine.

[49]  Y. Chawla,et al.  Nonalcoholic fatty liver disease in India--how much? How soon? , 2005, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[50]  Y. Chawla,et al.  Prevalence of obesity, diabetes mellitus and hyperlipidaemia in patients with cryptogenic liver cirrhosis. , 2004, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[51]  Shohei Matsuzaki,et al.  Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background , 2003, Journal of Gastroenterology.

[52]  J. Everhart,et al.  Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. , 2003, Gastroenterology.

[53]  D. Amarapurkar,et al.  Chronic liver disease in diabetes mellitus. , 2002, Tropical gastroenterology : official journal of the Digestive Diseases Foundation.

[54]  Anoop Misra,et al.  Insulin resistance syndrome (metabolic syndrome) and Asian Indians , 2002 .

[55]  K. Lee Metabolic significance of non-alcoholic fatty liver disease in non-obese adults , 2002 .

[56]  Joseph Ae Diffuse liver disease. , 1994, Clinics in diagnostic ultrasound.

[57]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.

[58]  Y Yajima,et al.  Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. , 1983, The Tohoku journal of experimental medicine.